ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,186.25
0.11%
US Tech 100
17,617.20
0.04%
다우존스 지수
38,877.16
0.06%
Bitcoin
63,037.06
-0.21%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Mirati Therapeutics Inc (MRTX)

  7. Mirati Therapeutics Inc (MRTX) 뉴스

MRTX Mirati Therapeutics Inc

58.70
0.00 (0.00%)
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Mirati Therapeutics Inc MRTX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 58.70 09:00:00
개장가 저가 고가 종가 전일 종가
58.70
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
15/02/202404:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202423:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03/02/202406:05EDGAR2Form 15-12G - Securities registration termination [Section..
25/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
24/01/202410:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202410:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202410:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202410:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202410:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202410:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202410:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/01/202423:31EDGAR2Form S-8 POS - Securities to be offered to employees in..
23/01/202423:30EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
23/01/202423:28EDGAR2Form POS AM - Post-Effective amendments for registration..
23/01/202423:27EDGAR2Form POS AM - Post-Effective amendments for registration..
23/01/202422:48EDGAR2Form 8-K - Current report
19/01/202406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202406:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202422:00PRNUSEuropean Commission Approves KRAZATI (adagrasib) as a..
10/01/202407:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202407:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202408:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202408:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202408:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202407:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202407:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202306:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/12/202306:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202321:30EDGAR2Form 8-K - Current report
15/12/202307:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202306:30EDGAR2Form 8-K - Current report
06/12/202322:29EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/12/202306:43EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/11/202306:45EDGAR2Form 8-K - Current report
15/11/202322:49EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/11/202321:30PRNUSMirati Therapeutics Receives Positive Opinion from CHMP for..
06/11/202322:05EDGAR2Form 8-K - Current report
06/11/202322:00PRNUSMirati Therapeutics Reports Third Quarter 2023 Financial..
06/11/202321:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202306:19PRNUSMirati Therapeutics Receives Approval from the MHRA for..
02/11/202320:30EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
02/11/202320:30GLOBEKura Oncology and Mirati Therapeutics Enter into Clinical..
24/10/202306:31EDGAR2Form PREM14A - Preliminary proxy statements relating to..
18/10/202305:00PRNUSMirati Presents Late-Breaking Results Evaluating the..
11/10/202320:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/10/202320:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/10/202320:33EDGAR2Form 8-K - Current report
10/10/202320:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..

최근 히스토리

NASDAQ
MRTX
Mirati Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유